Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Figure 2 | BMC Immunology

Figure 2

From: CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: Use of multiple peptide sets increases the detectable breadth of the CTL response

Figure 2

Magnitude of CTL responses measured for each subject in response to either Gag (A) or Nef (B) peptide sets (Con = consensus; Iso = isolate). For each study subject all detected ELIspot responses against each peptide set were totaled (expressed as SFC/106 PBMC) and plotted beside each other.

Back to article page